<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Functional classification of polycystic ovary syndrome according to source of androgen excess</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Functional classification of polycystic ovary syndrome according to source of androgen excess</h1>
<div class="graphic"><div class="figure"><div class="ttl">Functional classification of polycystic ovary syndrome according to source of androgen excess</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="20%"></colgroup><colgroup span="4" width="15%"></colgroup> <tbody> <tr class="divider_bottom"> <td class="subtitle1">PCOS functional type</td> <td class="subtitle1">Source of androgen</td> <td class="subtitle1">GnRHa test:<br/> 17OHP response</td> <td class="subtitle1">DAST testosterone response</td> <td class="subtitle1">ACTH test:<br/> DHEA response</td> <td class="subtitle1">Prevalence among PCOS</td> </tr> <tr class="divider_bottom"> <td>Typical PCOS (PCOS-T)</td> <td>Primary FOH (typical FOH)</td> <td class="centered">High<sup>¶</sup></td> <td class="centered">High in 92.5%</td> <td class="centered">High in 28% (associated FAH)</td> <td class="centered">67%<sup>Δ</sup></td> </tr> <tr> <td rowspan="3">Atypical PCOS (PCOS-A)</td> <td class="divider_bottom">Primary FOH (atypical FOH)</td> <td class="centered divider_bottom">Normal<sup>¶</sup></td> <td class="centered divider_bottom">High</td> <td class="centered divider_bottom">High in 30% (associated FAH)</td> <td class="centered divider_bottom">20%</td> </tr> <tr class="divider_bottom"> <td>Isolated primary FAH (isolated FAH)</td> <td class="centered">Normal</td> <td class="centered">Normal</td> <td class="centered">High</td> <td class="centered">5%</td> </tr> <tr> <td>PCOS without FOH or FAH (atypical PCOS of obesity or idiopathic atypical PCOS)</td> <td class="centered">Normal</td> <td class="centered">Normal</td> <td class="centered">Normal</td> <td class="centered">8%</td> </tr> </tbody></table></div><div class="graphic_lgnd">The FOH seen in two-thirds of PCOS cases is distinguished by 17OHP hyperresponsiveness to stimulation testing with GnRHa. However, in one-third, it is detected only by an elevated testosterone in response to a DAST. FAH is distinguished by DHEA hyperresponse to ACTH, which correlates with the DHEAS level. FAH occurs most often concomitantly with FOH, but it can also occur in the absence of FOH (isolated FAH). Text (high versus normal) indicates defining characteristics; percentages indicate experimentally determined prevalence of abnormality.</div><div class="graphic_footnotes"><p>PCOS: polycystic ovary syndrome; GnRHa: gonadotropin-releasing hormone agonist; 17OHP: 17-hydroxyprogesterone; DAST: dexamethasone androgen-suppression test; ACTH: adrenocorticotropic hormone (corticotropin); DHEA: dehydroepiandrosterone; FOH: functional ovarian hyperandrogenism; FAH: functional adrenal hyperandrogenism.</p>
<p>* Based on data of Rosenfield RL, et al. Determination of the source of androgen excess in functionally atypical PCOS by a short DAST and a low-dose ACTH test<sup>[1]</sup>.</p>
<p>¶ "High" versus "normal" denotes defining characteristics; percentages indicate experimentally determined prevalence of abnormality.</p>
Δ Prevalence determined from an age-matched subgroup (n = 60) of an original cohort (n = 99) in which 69% had PCOS-T.</div><div class="graphic_reference">Reference:
<ol>
<li>Rosenfield RL, Mortensen M, Wroblewski K, et al. Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test. Hum Reprod 2011; 26:3138.</li>
</ol>
<p class="extra_spacing_top">Modified from: Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocrine Reviews 2016; 37:467. By permission of Oxford University Press on behalf of The Endocrine Society. Copyright © 2016.</p></div><div id="graphicVersion">Graphic 94838 Version 16.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
